Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
108.14
(
0.00%
)
Bitcoin
67,909.39
(
0.11%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 220492

Thursday, 05/16/2019 11:50:19 AM

Thursday, May 16, 2019 11:50:19 AM

Post# of 257269
EPIX acquires RLM for $3.19/sh* in stock—a 3% discount to yesterday’s close:

https://www.prnewswire.com/news-releases/agreement-reached-for-essa-pharma-to-acquire-realm-therapeutics-300851546.html

This is effectively a financing transaction for EPIX insofar as EPIX is buying RLM for its approximate cash value per share. The nominal deal price is $21.5M.

(RLM used to trade on the London exchange as RLM.L.)

*Based on EPIX’s 5/15/19 closing price.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now